Evidence map›Paper›PMID 29581252›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Global increase and geographic convergence in antibiotic consumption between 2000 and 2015.

Eili Y Klein, Thomas P Van Boeckel, Elena M Martinez, Suraj Pant, Sumanth Gandra, Simon A Levin, Herman Goossens, Ramanan Laxminarayan

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1,176 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,176citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1,176 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Gut microbes · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Non-prescription antibiotics dispensing for common infections using simulated patients.Exploratory research in clinical and social pharmacy · 2026
    Article
  19. Article
  20. Article

1,116 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Eili Y KleinCenter for Disease Dynamics, Economics & Policy, Washington, DC 20005; klein@cddep.org slevin@princeton.edu.ORCID 0000-0002-1304-5289
Thomas P Van BoeckelInstitute of Integrative Biology, ETH Zürich, CH-8006 Zürich, Switzerland.
Elena M MartinezCenter for Disease Dynamics, Economics & Policy, Washington, DC 20005.
Suraj PantCenter for Disease Dynamics, Economics & Policy, Washington, DC 20005.
Sumanth GandraCenter for Disease Dynamics, Economics & Policy, Washington, DC 20005.
Simon A LevinDepartment of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ 08544; klein@cddep.org slevin@princeton.edu.
Herman GoossensLaboratory of Medical Microbiology, Vaccine & Infectious Diseases Institute, University of Antwerp, 2610 Antwerp, Belgium.
Ramanan LaxminarayanCenter for Disease Dynamics, Economics & Policy, Washington, DC 20005.ORCID 0000-0002-1390-9016

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tracking antibiotic consumption patterns over time and across countries could inform policies to optimize antibiotic prescribing and minimize antibiotic resistance, such as setting and enforcing per capita consumption targets or aiding investments in alternatives to antibiotics. In this study, we analyzed the trends and drivers of antibiotic consumption from 2000 to 2015 in 76 countries and projected total global antibiotic consumption through 2030. Between 2000 and 2015, antibiotic consumption, expressed in defined daily doses (DDD), increased 65% (21.1-34.8 billion DDDs), and the antibiotic consumption rate increased 39% (11.3-15.7 DDDs per 1,000 inhabitants per day). The increase was driven by low- and middle-income countries (LMICs), where rising consumption was correlated with gross domestic product per capita (GDPPC) growth (

Indexed as

Anti-Bacterial AgentsBacterial InfectionsDrug Resistance, MicrobialEconomicsHealth Services AccessibilityHumansAnti-Bacterial Agentsantibioticsantibiotic stewardshipantimicrobial resistancedefined daily doseslow-income countries

Identifiers

PMID29581252
PMCPMC5899442

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.